Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

14.71
-0.1990-1.33%
Volume:1.19M
Turnover:17.38M
Market Cap:1.75B
PE:-12.71
High:14.95
Open:14.95
Low:14.13
Close:14.91
Loading ...

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr

Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks
·
29 Apr

Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
24 Apr

Arcutis Biotherapeutics: Buy Rating Affirmed Amid Positive Long-Term Outlook and Strategic Growth Potential

TIPRANKS
·
23 Apr

Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

GlobeNewswire
·
17 Apr

Arcutis Biotherapeutics Promotes Vairavan to CFO as Topper Plans Retirement

Dow Jones
·
11 Apr

Arcutis Biotherapeutics Names New Chief Financial Officer

MT Newswires Live
·
11 Apr

Arcutis Biotherapeutics CFO David Topper to retire, Latha Vairavan to succeed

TIPRANKS
·
11 Apr

BRIEF-Arcutis Announces Chief Financial Officer Transition

Reuters
·
11 Apr

Arcutis Announces Chief Financial Officer Transition

THOMSON REUTERS
·
11 Apr

Arcutis Biotherapeutics Inc - CFO David Topper to Retire

THOMSON REUTERS
·
11 Apr

Press Release: Arcutis Announces Chief Financial Officer Transition

Dow Jones
·
11 Apr

Arcutis Biotherapeutics Price Target Maintained With a $20.00/Share by Needham

Dow Jones
·
09 Apr

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

Arcutis Biotherapeutics Price Target Maintained With a $20.00/Share by Needham

Dow Jones
·
03 Apr

Strategic Advantage and Market Confidence: Arcutis Biotherapeutics’ Extended Exclusivity and Buy Rating Amidst Competitive Risks

TIPRANKS
·
03 Apr

Why Arcutis Biotherapeutics Inc. (ARQT) Went Up On Wednesday?

Insider Monkey
·
03 Apr

Arcutis Biotherapeutics (ARQT) Receives a Buy from Mizuho Securities

TIPRANKS
·
03 Apr

BRIEF-Arcutis And Padagis Agree To Stay Patent Lawsuit

Reuters
·
03 Apr

BUZZ-Arcutis rises after halting patent dispute with Padagis

Reuters
·
03 Apr